Matthias Peipp
Professor - Mildred Scheel & Head of Research University of Kiel
Matthias Peipp is a molecular biologist and immunologist, head of the Division of Antibody-Based Immunotherapy at Christian-Albrechts-Universität zu Kiel (Kiel, Germany). Matthias is an recognized expert in the field of bispecific antibodies and immunotherapy, with over 150 scientific publications. His work is focused on modulating antibody effector functions and strategies to improve recruitment and activation of various immune cell populations. Besides his academic appointment he acts as consultant and member of the scientific advisory boards of different biotechs.
Seminars
Wednesday 10th December 2025
Activating NK Cell Receptors as Trigger Molecules for Bispecific Antibodies to Enhance Anti-Tumour NK Cell Responses
3:00 pm
- Evaluating preclinical case studies of NKG2D or NKp30 engaging bispecific antibodies
- Synergy with FcγRIIIA engagement – discussing multispecific molecules and impact of molecule architecture vs combination approaches to improve synapse quality and PK profile
- Exploring opportunities for combination with adoptive NK cell transfer using a novel NK cell expansion technology for enhanced therapeutic impact
